The Australian–New Zealand SCAD observational cohort study: major adverse cardiovascular events are associated with ticagrelor combined with aspirin, FMD, and history of stroke

Journal:

European Heart Journal

Published:

2025-06-02

DOI:

10.1093/eurheartj/ehaf127

Affiliations:

4

Authors:

2

Go to article

Institutions	Authors	Share
Mayo Clinic, United States of America (USA)	1.000000	0.50
Icahn School of Medicine at Mount Sinai (ISMMS), MSHS, United States of America (USA)	0.333333	0.17
Victor Chang Cardiac Research Institute (VCCRI), Australia	0.333333	0.17
University of New South Wales (UNSW Sydney), Australia	0.333333	0.17

Interested in Cardiovascular Medicine and Haematology?